The Global Transgenic Animals Market is estimated to grow at an approximate CAGR of 8.60% from 2017 to 2023. Transgenic animals have a deliberately altered genetic make-up and are extensively exploited in the veterinary, medical sciences, and research sectors. The Americas leads the global transgenic animals market due to increasing prevalence of diabetes and cardiovascular disorders, growing biotechnology sector, and rising acceptance of transgenic products. Additionally, the presence of the market’s key players like Charles River, Cyagen Biosciences, and others within the region fuels the market growth. However, high cost and stringent FDA approval policies may restrain the market growth within the region.
Growing biotechnology sector followed by rising R&D expenses is estimated to be a major driver for the market growth during the forecast period. In 2016, the revenue generated by the emerging biotech industries across the globe was estimated to be around USD 139.4 billion. Moreover, increasing prevalence of cardiovascular diseases, diabetes, and other disorders along with the rising healthcare expenditures and growing awareness for the transgenic animals is boosting the market growth. According to the World Health Organization in 2017, cardiovascular diseases were the main cause of the deaths across the globe. It was estimated that in 2015, approximately 17.7 million people died from cardiovascular diseases, representing 31% of all the global deaths. Of these deaths, an estimated 7.4 million were due to the coronary heart diseases and 6.7 million were due to stroke.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/5464 .
Key Players for Transgenic Animals Market:
Cyagen Biosciences, Charles River, Creative-Biolabs, TRANS GENIC INC.., Ltd., Sutter Instrument Company, Bio-Rad Laboratories, Inc., Spinco Biotech Pvt Ltd., Abbott, Thermo Fisher Scientific Inc., Sigma-Aldrich Co., Accumold, and others are some of the major players for transgenic animals market.
Transgenic Animals Market Segmentation:
The Global Transgenic Animals Market is segmented on the basis of product, techniques, consumables, application, model organisms, and end-user.
On the basis of the product, the market is categorized into PCR, gene gun, microinjections, electroporator, and others. The PCR segment is sub-segmented into real-time PCR, digital PCR systems, and others. On the basis of the techniques, the market is segmented into retrovirus-mediated gene transfer, embryonic stem cell-mediated gene transfer, DNA microinjection, and others. On the basis of the consumables, the market is segmented into fluorescent probes, culture media, and others. On the basis of the application, the market is segmented into recombinant human proteins, monoclonal antibodies, xenotransplantation, and others. On the basis of the model organisms, the market is segmented into mice, rabbit, cows, and others. On the basis of the end-user, the market is segmented into biotechnology industries, research organizations, academic institutes, and others.
Regional Analysis:
The Americas dominate the transgenic animals market owing to increasing adoption of new technologies and huge patient population for diabetes and cardiovascular diseases. Additionally, rising healthcare expenditure, followed by the presence of developed economies and healthcare sector within the region fuels the market growth.
The transgenic animals market in Europe is the second largest. Rising research and development in the healthcare sector, huge patient population, and growing biotechnology sector are the major drivers for the market growth within the region. The U.K is the fourth-largest contributor to biotechnology research and development worldwide.
Asia Pacific region is the fastest growing market. Increasing awareness for transgenic animals and rising healthcare expenditures are the major drivers for the market growth within the region during the forecast period. Moreover, the presence of the developing economies like India and China which have a developing biotechnology sector within the region fuels the market growth. According to the Indian Brand Equity Foundation in 2017, the Indian biotech industry holds about 2% share of the global biotech industry. The biotechnology industry in India comprises of about 800 companies and is valued to be about USD 11.6 billion in 2017.
The Middle East & Africa has the least share in the transgenic animals market. The presence of poor economies and stringent government policies, especially in the African region restrains the market growth within the region. Majority of the market in the Middle East & Africa region is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure by the presence of the developed economies like Saudi Arabia, Kuwait, and Qatar within the region.
Get Discount @ https://www.marketresearchfuture.com/check-discount/5464 .
Table of Content:
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
TOC Continued….!
Ask to Experts @https://www.marketresearchfuture.com/enquiry/5464 .
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Email: akash.anand@marketresearchfuture.com
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/transgenic-animals-market-5464